158 related articles for article (PubMed ID: 32579760)
1. Correlation analysis of microribonucleic acid-155 and microribonucleic acid-29 with type 2 diabetes mellitus, and the prediction and verification of target genes.
Zhu J; Wang C; Zhang X; Qiu T; Ma Y; Li X; Pang H; Xiong J; Yang X; Pan C; Xie J; Zhang J
J Diabetes Investig; 2021 Feb; 12(2):165-175. PubMed ID: 32579760
[TBL] [Abstract][Full Text] [Related]
2. miR-4431 targets TRIP10/PRKD1 and impairs glucose metabolism.
Pan C; Li M; Wang J; Chu X; Xiong J; Yang X; Tang Y; Ma D; Yuan C; Zhu J; Chang Y; Zhang J; Wang C
J Diabetes Investig; 2022 Apr; 13(4):617-627. PubMed ID: 34800086
[TBL] [Abstract][Full Text] [Related]
3. miR-93-5p promotes insulin resistance to regulate type 2 diabetes progression in HepG2 cells by targeting HGF.
Zhou M; Hou Y; Wu J; Li G; Cao P; Chen W; Hu L; Gan D
Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760164
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal examination of pancreatic β-cell function in Japanese individuals.
Fujikawa R; Ito C; Kira S; Misumi M
J Diabetes Investig; 2020 Jan; 11(1):70-74. PubMed ID: 31069995
[TBL] [Abstract][Full Text] [Related]
5. Association between circulating microRNAs 486, 146b and 15b and serum betatrophin levels in obese; type 2 diabetic and non-diabetic children.
Mohany KM; Al Rugaie O; Al-Wutayd O; Al-Nafeesah A; Saleem TH
BMC Endocr Disord; 2020 Sep; 20(1):145. PubMed ID: 32988370
[TBL] [Abstract][Full Text] [Related]
6. Berberine Attenuates Development of the Hepatic Gluconeogenesis and Lipid Metabolism Disorder in Type 2 Diabetic Mice and in Palmitate-Incubated HepG2 Cells through Suppression of the HNF-4α miR122 Pathway.
Wei S; Zhang M; Yu Y; Lan X; Yao F; Yan X; Chen L; Hatch GM
PLoS One; 2016; 11(3):e0152097. PubMed ID: 27011261
[TBL] [Abstract][Full Text] [Related]
7. Docosahexaenoic acid inhibits vascular smooth muscle cell migration and proliferation by decreasing microRNA‑155 expression levels.
Yin X; Xu C; Xu Q; Lang D
Mol Med Rep; 2020 Oct; 22(4):3396-3404. PubMed ID: 32945419
[TBL] [Abstract][Full Text] [Related]
8. Micro ribonucleic acid-363 regulates the phosphatidylinositol 3-kinase/threonine protein kinase axis by targeting NOTCH1 and forkhead box C2, leading to hepatic glucose and lipids metabolism disorder in type 2 diabetes mellitus.
Peng YH; Wang P; He XQ; Hong MZ; Liu F
J Diabetes Investig; 2022 Feb; 13(2):236-248. PubMed ID: 34739190
[TBL] [Abstract][Full Text] [Related]
9. Risk and population attributable fraction of metabolic syndrome and impaired fasting glucose for the incidence of type 2 diabetes mellitus among middle-aged Japanese individuals: Aichi Worker's Cohort Study.
Kaneko K; Yatsuya H; Li Y; Uemura M; Chiang C; Hirakawa Y; Ota A; Tamakoshi K; Aoyama A
J Diabetes Investig; 2020 Sep; 11(5):1163-1169. PubMed ID: 32022993
[TBL] [Abstract][Full Text] [Related]
10. Relationship between natural killer cell activity and glucose control in patients with type 2 diabetes and prediabetes.
Kim JH; Park K; Lee SB; Kang S; Park JS; Ahn CW; Nam JS
J Diabetes Investig; 2019 Sep; 10(5):1223-1228. PubMed ID: 30618112
[TBL] [Abstract][Full Text] [Related]
11. Polydatin ameliorates lipid and glucose metabolism in type 2 diabetes mellitus by downregulating proprotein convertase subtilisin/kexin type 9 (PCSK9).
Wang Y; Ye J; Li J; Chen C; Huang J; Liu P; Huang H
Cardiovasc Diabetol; 2016 Feb; 15():19. PubMed ID: 26833058
[TBL] [Abstract][Full Text] [Related]
12. Association of glucose tolerance status with pancreatic β- and α-cell mass in community-based autopsy samples of Japanese individuals: The Hisayama Study.
Inaishi J; Saisho Y; Hirakawa Y; Yoshida D; Hata J; Mukai N; Watanabe Y; Oda Y; Itoh H; Ninomiya T
J Diabetes Investig; 2020 Sep; 11(5):1197-1206. PubMed ID: 32031300
[TBL] [Abstract][Full Text] [Related]
13. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
Højlund K
Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the effects of three kinds of glucose-lowering drugs on non-alcoholic fatty liver disease in patients with type 2 diabetes: A randomized, open-label, three-arm, active control study.
Kinoshita T; Shimoda M; Nakashima K; Fushimi Y; Hirata Y; Tanabe A; Tatsumi F; Hirukawa H; Sanada J; Kohara K; Irie S; Kimura T; Nakamura Y; Nishioka M; Obata A; Nakanishi S; Mune T; Kaku K; Kaneto H
J Diabetes Investig; 2020 Nov; 11(6):1612-1622. PubMed ID: 32329963
[TBL] [Abstract][Full Text] [Related]
15. Dysregulation of microRNA-125a contributes to obesity-associated insulin resistance and dysregulates lipid metabolism in mice.
Liu R; Wang M; Li E; Yang Y; Li J; Chen S; Shen WJ; Azhar S; Guo Z; Hu Z
Biochim Biophys Acta Mol Cell Biol Lipids; 2020 May; 1865(5):158640. PubMed ID: 31988048
[TBL] [Abstract][Full Text] [Related]
16. Increased risks of different grades of non-alcoholic fatty liver disease in prediabetic subjects with impaired fasting glucose and glucose tolerance, including the isolated glycosylated hemoglobin levels of 5.7-6.4% in a Chinese population.
Li CH; Chou YT; Shen WC; Lu FH; Yang YC; Wu JS; Chang CJ
J Diabetes Investig; 2020 Sep; 11(5):1336-1343. PubMed ID: 32270583
[TBL] [Abstract][Full Text] [Related]
17. Sustained fasting glucose oxidation and postprandial lipid oxidation associated with reduced insulin dose in type 2 diabetes with sodium-glucose cotransporter 2 inhibitor: A randomized, open-label, prospective study.
Kanazawa K; Uchino H; Shigiyama F; Igarashi H; Ikehara K; Yoshikawa F; Usui S; Miyagi M; Yoshino H; Ando Y; Kumashiro N; Hirose T
J Diabetes Investig; 2019 Jul; 10(4):1022-1031. PubMed ID: 30582774
[TBL] [Abstract][Full Text] [Related]
18. Serum 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid is associated with lipid profiles and might protect against non-alcoholic fatty liver disease in Chinese individuals.
Dai J; Yi J; Zhang S; Chen P; Jin H; Yu X; Zhang X
J Diabetes Investig; 2019 May; 10(3):793-800. PubMed ID: 30353682
[TBL] [Abstract][Full Text] [Related]
19. Plasma miR-193b-3p Is Elevated in Type 2 Diabetes and Could Impair Glucose Metabolism.
Hu H; Zhao M; Li Z; Nie H; He J; Chen Z; Yuan J; Guo H; Zhang X; Yang H; Wu T; He M
Front Endocrinol (Lausanne); 2022; 13():814347. PubMed ID: 35712251
[TBL] [Abstract][Full Text] [Related]
20. Diabetes and branched-chain amino acids: What is the link?
Bloomgarden Z
J Diabetes; 2018 May; 10(5):350-352. PubMed ID: 29369529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
